Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples